Skip to content

Paolini John F.

Reporting owner on Forms 3, 4 and 5, CIK 1741533.

Paolini John F. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-17.

Issuers

IssuerRoles in the latest filingFilingsLast filed
KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430officer (CHIEF MEDICAL OFFICER)22026-11-17

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-13M exercised+29,670$10.3699,592Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-13M exercised+4,994$11.1104,586Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-13M exercised+3,723$11.97108,309Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-13M exercised+3,144$12.97111,453Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-13M exercised+2,595$15.52114,048Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-13M exercised-29,670$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-13M exercised-4,994$054,936Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-13M exercised-3,723$056,207Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-13M exercised-3,144$038,256Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-13M exercised-2,595$047,405Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+6,455$30.9376,377Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+11,958$17.9288,335Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-899$92.3787,436Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-16,810$93.4270,626Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-704$94.0969,922Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-6,455$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-11,958$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+38,545$30.93108,467Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+39,042$17.92147,509Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-41,789$92.02105,720Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-16,056$92.8589,664Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-6,841$93.9182,823Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-4,821$94.8678,002Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-4,000$95.9774,002Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-1,925$97.0672,077Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-2,155$97.7769,922Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-38,545$06,455Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-39,042$011,958Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001741533-26-000014 Kiniksa Pharmaceuticals International, plc2026-11-17
Form 4 0001741533-26-000012 Kiniksa Pharmaceuticals International, plc2026-11-03